V. Lee

发表

Virulizin, a novel immunotherapy agent, stimulates TNFalpha expression in monocytes/macrophages in vitro and in vivo.

S. Der, M. Cao, Ningping Feng, 2007, International immunopharmacology.

Chemokine receptors as targets for cancer therapy.

V. Lee, É. Chevalier, Xuesong Wu, 2009, Current pharmaceutical design.

Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages

S. Der, M. Cao, Ningping Feng, 2005, Cancer Immunology, Immunotherapy.

CCR 10-Expressing T Cells Contact Sensitizer Recruits Nodes following Topical Application of a Epidermal CCL 27 in Skin-Draining Lymph Cutting Edge : Rapid Accumulation of

Hong Zhang, V. Lee, W. Olszewski, 2008 .

Cutting Edge: Rapid Accumulation of Epidermal CCL27 in Skin-Draining Lymph Nodes following Topical Application of a Contact Sensitizer Recruits CCR10-Expressing T Cells1

Hong Zhang, V. Lee, W. Olszewski, 2008, The Journal of Immunology.

Antigen presentation in retroviral vector-mediated gene transfer in vivo.

S. Chada, V. Lee, C. Surh, 1997, Proceedings of the National Academy of Sciences of the United States of America.

TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets

V. Lee, Tran Truong, M. Wong, 2017, PloS one.

IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo

M. Cao, Ningping Feng, X. Gu, 2010, Cancer Immunology, Immunotherapy.

Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors

S. Der, M. Cao, Ningping Feng, 2008, Cancer Immunology, Immunotherapy.

NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin

M. Cao, Ningping Feng, X. Gu, 2005, Cancer Immunology, Immunotherapy.

Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates

S. Chada, V. Lee, D. Jolly, 1994, Journal of virology.

CCR7 regulates B16 murine melanoma cell tumorigenesis in skin

Hong Zhang, V. Lee, L. Fang, 2008, Journal of leukocyte biology.

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding

S. Trudel, J. Koropatnick, S. Viau, 2016, Clinical Cancer Research.

Developing Novel Oncolytic Adenoviruses through Bioselection

A. Balmain, T. Hermiston, A. Fattaey, 2003, Journal of Virology.

, through Bioselection Developing Novel Oncolytic Adenoviruses

A. Balmain, T. Hermiston, A. Fattaey, 2003 .

Abstract 2653: The anti-myeloma activity of TTI-621 (SIRPαFc), a CD47-blocking immunotherapeutic, is enhanced when combined with a proteasome inhibitor

V. Lee, G. Lin, L. D. Johnson, 2017 .

Abstract 2709: TTI-622 (SIRPα-IgG4 Fc), a CD47-blocking innate immune checkpoint inhibitor, suppresses tumor growth and demonstrates enhanced efficacy in combination with antitumor antibodies in both hematologic and solid tumor models

J. Koropatnick, R. Figueredo, S. M. Vareki, 2018, Immunology.

Herpes simplex Virus-1 infection in human primary corneal epithelial cells is blocked by a stapled peptide that targets processive DNA synthesis.

R. Ricciardi, Hancheng Guan, C. Mitchell, 2020, The ocular surface.

Macrophages play a critical role in the anti-tumor activity of Virulizin.

Ningping Feng, M. Wang, Jim A. Wright, 2003, International journal of oncology.

Abstract 3854: Preclinical characterization of a novel non-cyclic dinucleotide small molecule STING agonist with potent antitumor activity in mice

V. Lee, Zezhou Wang, G. Lin, 2019, Experimental and Molecular Therapeutics.